Overview

Clinical Trial Comparing Two Bladder Instillations for IC/BPS

Status:
Completed
Trial end date:
2020-10-23
Target enrollment:
0
Participant gender:
Female
Summary
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a condition that results in long-term bladder and pelvic pain. IC/BPS affects women more often than men. How the disorder develops is not completely known. Bladder instillation is a commonly used treatment in which a mixture of different ingredients are passed into the bladder to help IC/BPS symptoms. There is room to learn more about bladder instillations and which ingredients in them work best. The purpose of this study is to compare the effectiveness of a bladder instillation that contains a steroid (triamcinolone acetonide) to a bladder instillation that does not contain a steroid to treat IC/BPS in women. The study hypothesis is that women with IC/BPS treated with bladder instillations that contain a steroid will have improved outcomes compared to women treated with bladder instillations that do not contain a steroid.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Olivia Cardenas-Trowers, M.D.
Treatments:
Gabapentin
gamma-Aminobutyric Acid
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- Women 18 years and older

- Women with IC/BPS who have a score of ≥ 6 on either index (problem or symptom index)
of the O'Leary-Sant questionnaire who have selected bladder instillations as part of
their IC/BPS treatment

- Suitability for follow-up

Exclusion Criteria:

- Contraindications and/or allergies to the ingredients used in the bladder
instillations

- Diagnosis of idiopathic thrombocytopenic purpura

- Does not desire to undergo bladder instillation therapy or unwilling to undergo
bladder instillation therapy on schedule mandated by study

- Have a known alternative diagnosis explaining bladder pain symptoms that would
preclude the diagnosis of IC/BPS (e.g. radiation cystitis, active urinary tract
infection with bacteria or fungus treated within last 2 weeks or diagnosed at index
visit, bladder injury or trauma within the last 30 days)

- Inability to speak or read English

- Bladder instillation within the past 4 weeks